<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>By means of clinical and instrumental diagnosis the authors displayed a high effectiveness in the preventive treatment of patients with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:e sem="disease" ids="C0020538" disease_type="Disease or Syndrome" abbrv="HTN">hypertensive disease</z:e> by <z:chebi fb="5" ids="28304">heparin</z:chebi> in the period of remission </plain></SENT>
<SENT sid="1" pm="."><plain>At the same time following treatment some patients especially with <z:e sem="disease" ids="C0020538" disease_type="Disease or Syndrome" abbrv="HTN">hypertensive disease</z:e> revealed a marked activation of the hypercoagulative blood properties which exceeded the intial level </plain></SENT>
<SENT sid="2" pm="."><plain>The authors discuss the possible mechanisms of this reaction </plain></SENT>
</text></document>